P V Pigott. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Amitriptyline/therapeutic useAnxiety/drug therapyCentral Nervous System/drug effectsClinical Trials as TopicDepression/drug therapyDiazepam/therapeutic useDoxepin/therapeutic useDrug CombinationsFluphenazine/administration & dosageFluphenazine/adverse effectsFluphenazine/therapeutic useHeart Conduction System/drug effectsHumansMotor Activity/drug effectsNortriptyline/administration & dosageNortriptyline/adverse effectsNortriptyline/therapeutic usePerphenazine/therapeutic usePlacebosPsychiatric Status Rating ScalesVision Disorders/chemically induced
Substances： See more » Drug CombinationsPlacebosDoxepinAmitriptylineNortriptylinePerphenazineDiazepamFluphenazine
Year: 1972 PMID： 4589400 DOI： 10.1185/03007997209111142
Source DB: PubMed Journal: Curr Med Res Opin ISSN： 0300-7995 Impact factor: 2.580